Photic Retinopathy After Cataract Surgery in Diabetic Patients

Çetinkaya, Altuğ; Yılmaz, Gürsel; Akova, Yonca A.

doi:10.1097/01.iae.0000254895.78766.af

Cited by 18 publications

(10 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Increases in the duration and complexity of phacoemulsification surgery have been identified as important risk factors for DR progression and subsequent visual compromise [421]. Diabetic patients may also be more vulnerable to photic retinopathy, and intraoperative precautions such as reducing operating time with a senior surgeon should be considered to minimise this risk [432].…”

Section: Intra-operativementioning

confidence: 99%

Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working Group

Amoaku

Ghanchi

Bailey

et al. 2020

Eye

134

121

View full text Add to dashboard Cite

The management of diabetic retinopathy (DR) has evolved considerably over the past decade, with the availability of new technologies (diagnostic and therapeutic). As such, the existing Royal College of Ophthalmologists DR Guidelines (2013) are outdated, and to the best of our knowledge are not under revision at present. Furthermore, there are no other UK guidelines covering all available treatments, and there seems to be significant variation around the UK in the management of diabetic macular oedema (DMO). This manuscript provides a summary of reviews the pathogenesis of DR and DMO, including role of vascular endothelial growth factor (VEGF) and non-VEGF cytokines, clinical grading/classification of DMO vis a vis current terminology (of centre-involving [CI-DMO], or non-centre involving [nCI-DMO], systemic risks and their management). The excellent UK DR Screening (DRS) service has continued to evolve and remains world-leading. However, challenges remain, as there are significant variations in equipment used, and reproducible standards of DMO screening nationally. The interphase between DRS and the hospital eye service can only be strengthened with further improvements. The role of modern technology including optical coherence tomography (OCT) and wide-field imaging, and working practices including virtual clinics and their potential in increasing clinic capacity and improving patient experiences and outcomes are discussed. Similarly, potential roles of home monitoring in diabetic eyes in the future are explored. The role of pharmacological (intravitreal injections [IVT] of anti-VEGFs and steroids) and laser therapies are summarised. Generally, IVT anti-VEGF are offered as first line pharmacologic therapy. As requirements of diabetic patients in particular patient groups may vary, including pregnant women, children, and persons with learning difficulties, it is important that DR management is personalised in such particular patient groups. First choice therapy needs to be individualised in these cases and may be intravitreal steroids rather than the standard choice of anti-VEGF agents. Some of these, but not all, are discussed in this document.

show abstract

Section: Intra-operativementioning

confidence: 99%

Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working Group

Amoaku

Ghanchi

Bailey

et al. 2020

Eye

134

121

View full text Add to dashboard Cite

show abstract

“…[ 65 ] Cetinkaya et al . [ 66 ] showed that photic retinopathy during cataract surgery was more prevalent in diabetic patients than nondiabetics. The mere presence of diabetes does not increase the risk of intraoperative complications such as posterior capsular rupture, zonular dehiscence, and vitreous loss.…”

Section: Discussionmentioning

confidence: 99%

Cataract surgery in diabetes mellitus: A systematic review

Kelkar

Mehta

et al. 2018

Indian J Ophthalmol

View full text Add to dashboard Cite

India is considered the diabetes capital of the world, and a significant proportion of patients undergoing cataract surgery are diabetic. Considering this, we reviewed the principles and guidelines of managing cataract in patients with diabetes. The preoperative, intraoperative, and postoperative factors are of paramount importance in the management of diabetic cataract patients. Particularly, the early recognition and treatment of diabetic retinopathy or maculopathy before cataract surgery influence the final visual outcome and play a major role in perioperative decision-making. Better understanding of various factors responsible for favorable outcome of cataract surgery in diabetic patients may guide us in better overalll management of these patients and optimizing the results.

show abstract

“…In cases with NVI, bleeding in the anterior chamber during or after surgery should also be kept in mind. Photic retinopathy during cataract surgery, especially surgeries of a longer duration, was also more prevalent in diabetic patients than nondiabetics[66].…”

Section: Cataract Surgery In Diabetic Patientsmentioning

confidence: 99%

Cataract in diabetes mellitus

Kızıltoprak¹,

Tekin²,

İnanç³

et al. 2019

WJD

200

132

View full text Add to dashboard Cite

Diabetes mellitus (DM) is a chronic systemic disease that has increases in prevalence over time. DM can affect all ocular structures, with cataract being the most common ocular complication. Cataract is the leading cause of blindness worldwide. Due to several mechanisms, there is an increased incidence of cataract formation in the diabetic population. Advancements in technology have now made cataract surgery a common and safe procedure. However, the diabetic population is still at risk of vision-threatening complications, such as diabetic macular edema (ME), postoperative ME, diabetic retinopathy progression, and posterior capsular opacification.

show abstract

Photic Retinopathy After Cataract Surgery in Diabetic Patients

Abstract: Diabetic patients may be more vulnerable to photic injury. Surgeons should take precautions to prevent PR when performing cataract surgery on diabetic patients.

Cited by 18 publications

References 23 publications

Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working Group

Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working Group

Cataract surgery in diabetes mellitus: A systematic review

Cataract in diabetes mellitus

Contact Info

Product

Resources

About